Dimensional Fund Advisors’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
Dimensional Fund Advisors's CCCC Position: Q3 2026 in Review
Dimensional Fund Advisors increased its C4 Therapeutics (CCCC) stake by 17% in Q3 2026, buying an estimated $733K and bringing the position to 1,384,966 shares worth $4.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2517.
Dimensional Fund Advisors first reported a position in CCCC in Q3 2022 and has held it in 16 quarters since. The position peaked at $5.55M in Q2 2026. 28 funds tracked by Wall St. Rank hold CCCC as of Q3 2026.
- Dimensional Fund Advisors held 1,384,966 shares of C4 Therapeutics worth $4.61M as of Q3 2026.
- Dimensional Fund Advisors bought 196,459 C4 Therapeutics shares in Q3 2026, an estimated $733K.
- C4 Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2517 holding.
- Dimensional Fund Advisors first reported a position in C4 Therapeutics in Q3 2022 and has held it in 16 quarters since.
- Dimensional Fund Advisors's C4 Therapeutics position peaked at $5.55M in Q2 2026.
- 28 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.